Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-Human TCR Antibody (NKTT320)

Catalog #:   DHK10202 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHK10202

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG

Target

T cell receptor, T-cell receptor, TCR

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

NKTT320, NKTT 320, NKTT-320

Clone ID

NKTT320

Data Image
References

HLA-DQ monomer-based enrichment of alloreactive CD4 T cells., PMID:40502077

Genetic deletion of microsomal prostaglandin E synthase-1 promotes imiquimod-induced psoriasis in mice., PMID:40481552

Immune age is correlated with decreased TCR clonal diversity and antibody response to SARS-CoV-2., PMID:40481111

In vivo labeling reveals that degranulation is increased under supraphysiological TCR stimulation, but not infection, in CD8+ T cells from old mice., PMID:40478430

Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides., PMID:40476553

The immunosuppressive effect of glucocorticoids in human primary T cells is mainly mediated via a rapid inhibition of the IL-2/IL-2R signaling axis., PMID:40468327

Randomized field trial of a therapeutic vaccine against Trypanosoma cruzi natural infection in dogs and correlates for efficacy., PMID:40462951

Development of a CD3ε mAb that can identify and in vitro activate T cells in large yellow croaker (Larimichthyscrocea)., PMID:40449701

Targeting CD8+ T cells in cardiovascular diseases - current options and therapeutic perspectives., PMID:40448685

Bispecific antibody targeting shared indel-derived neoantigen of APC., PMID:40443649

T cell receptor mimic CAR T cells targeting cathepsin G signal peptide., PMID:40437170

TCRCluster: a novel approach to T-cell receptor latent featurization and clustering using contrastive learning-guided two-stage variational autoencoders., PMID:40432791

Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases., PMID:40422256

High-fidelity in silico generation and augmentation of TCR repertoire data using generative adversarial networks., PMID:40419551

Engaging T cells for cleanup., PMID:40416957

Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial., PMID:40414961

A TCR nanovesicle antibody for redirecting T cells and reversing immunosuppression as a tumor immunotherapy strategy., PMID:40412660

A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and Therapeutics., PMID:40402459

A Robust Quantitative Multiplex PCR for T-cell Receptor Repertoire Sequencing from Formalin-Fixed Paraffin-Embedded Samples., PMID:40402454

Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells., PMID:40401520

Efficacy of three lung cancer prediction models in diagnosing benign and malignant pulmonary nodules., PMID:40386274

Effect and mechanism of the miR-1284/EIF4A1 axis on the cGAS-STING pathway under radiotherapy., PMID:40386253

Single cell transcriptomics correlate avian coronavirus prime vaccination efficacy with antigen-presenting cell preference., PMID:40382358

Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing., PMID:40375902

Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms., PMID:40349527

Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID., PMID:40346201

Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma., PMID:40345188

Case Report: Co-occurrence of tubulitis and SARS-CoV-2 specific T-cells in a kidney transplant recipient., PMID:40343198

The Quest for Antibodies and Other Acquired Immune Receptors: A Historical Perspective., PMID:40341816

Concept CARs are picking up speed., PMID:40340247

Implementation of a CAR-T cell therapy program in India., PMID:40336352

Clonal rearrangements of B and T lymphocytes in minor salivary gland biopsies of Sjögren's disease patients with a focus score of ≥1., PMID:40335403

Donor-reactive T cells and innate immune cells promote pig-to-human decedent xenograft rejection., PMID:40313748

Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant., PMID:40294012

Interferon-γ and IL-27 positively regulate type 1 regulatory T cell development during adaptive tolerance., PMID:40276760

T-cell receptor dynamics in digestive system cancers: a multi-layer machine learning approach for tumor diagnosis and staging., PMID:40264789

Transient intracellular expression of PD-L1 and VEGFR2 bispecific nanobody in cancer cells inspires long-term T cell activation and infiltration to combat tumor and inhibit cancer metastasis., PMID:40253320

Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific., PMID:40239619

Circulating Tissue Specific Extracellular Vesicles for Noninvasive Monitoring of Acute Cellular Rejection in Clinical Heart Transplantation., PMID:40238644

Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination., PMID:40235093

Reading of human acute immune dynamics in omicron SARS-CoV-2 breakthrough infection., PMID:40231451

Characteristics and specific differential gene analysis of the TCR immune repertoire in secondary adult HLH lymphocytes., PMID:40228699

Induction and Assessment of Activation in Rat Effector CD4+ Memory Th Cells., PMID:40220232

TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancer., PMID:40216662

Anoctamin 9 determines Ca2+ signals during activation of T-lymphocytes., PMID:40207216

Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response., PMID:40205519

Mapping the extracellular molecular architecture of the pAg-signaling complex with α-Butyrophilin antibodies., PMID:40204806

Recognition of different subsets of alloreactive T cells by activation-induced markers., PMID:40204006

ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesis., PMID:40198121

T cell characteristics in individuals with different immune responses after hepatitis B vaccination., PMID:40195671

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-Human TCR Antibody (NKTT320) [DHK10202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only